Kingdon Capital Management »

Cytokinetics shares owned by Kingdon Capital Management

Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by Kingdon Capital Management from 13F filings

Historical chart of Kingdon Capital Management investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by Kingdon Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by Kingdon Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $14M 267k 54.18
2024-03-31 $8.1M 116k 70.11

More positions owned by Kingdon Capital Management

Invesco Exchange Traded Fd T S&p500 Eql Wgt Put Option (RSP)
Insmed Com Par $.01 Call Option (INSM)
Visa Com Cl A (V)
Select Sector Spdr Tr Financial Put Option (XLF)
Ftai Aviation SHS (FTAI)
Api Group Corp Com Stk (APG)
Bank of America Corporation Call Option (BAC)
Ishares Tr Msci Emg Mkt Etf Call Option (EEM)
Ishares Tr Russell 2000 Etf Put Option (IWM)
UnitedHealth (UNH)
Meta Platforms Cl A Put Option (META)
Guardant Health (GH)
Advanced Micro Devices (AMD)
Tenet Healthcare Corp Com New (THC)
Syndax Pharmaceuticals (SNDX)

View all positions for Kingdon Capital Management

Top funds holding Cytokinetics

BlackRock
Vanguard Group
FMR
T. Rowe Price Investment Management
State Street Corporation
Darwin Global Management
Bank of America Corporation
Wellington Management Company
Armistice Capital
Geode Capital Management
Rtw Investments
T. Rowe Price Associates
Pentwater Capital Management
Boxer Capital
Vestal Point Capital

View all funds holding Cytokinetics